Çalışan Türk Kadınlarında Premenstruel Sendrom ve Premenstruel Distrofik Bozukluk Prevalansı ve İş Performansına Etkisi

Amaç: Çalışan Türk kadınlarında premenstruel sendrom (PMS) ve premenstruel distrofik bozukluğun (PMDB) prevalansı ve iş performansı üzerindeki olumsuz etkisini belirlemektir. Gereç ve Yöntem: Bu çapraz kesitsel çalışmada, Acıbadem Kozyatağı Hastanesi Jinekoloji Polikliniği'ne 2013-2015 tarihleri arasında başvuran, PMS/PMDB tanısı alan 185 çalışan kadına premensturel semptom ve etkilerini değerlendiren bir anket uygulanmıştır. Bulgular: Herbir premensturel semptomun sıklığı yüksek idi. Orta-ağır PMS ve PMDB prevalansı sırasıyla %11.2 ve %3.9 idi. Çalışan kadınların %45.7' i iş performansının etkilenmesinden şikayetçi idi. 'Yönetici konumunda çalışmak' (OO8.70,95% GA:1.22-120.0), 'konsantrasyon güçlüğü' (OO3.17,95% GA:1.05-10.6), 'bitkinlik-enerji yokluğu' (OO5.94,95% GA: 1.33-34.6) çalışma performansını olumsuz yönde arttıran risk faktörleri idi. Sonuç: Bu çalışma premensturel semptomların sadece günlük aktiviteleri değil aynı zamanda iş performansını da çalışan kadınlarda olumsuz yönde etkilediğini göstermiştir.

Anahtar Kelimeler:

PMS, PMDD, çalışan kadınlar

The Prevalence and Impact of Premenstrual Syndrome and Premenstrual Dysphoric Disorder On Work Performance in Turkish Employee Women

Objective: To determine the prevalence and impact of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) in Turkish employee women, with a focus on their disruption of work performance. Materials and Methods: In this cross-sectional study, Premenstrual Symptoms Questionnaire (PSQ) results of the 185 working women who applied to Acıbadem Kozyatagı Hospital Gynecology Clinic between 2013-2015 with the diagnosis of PMS/PMDD were analyzed. Results: The prevalence of each premenstrual symptom was high. The prevalence of moderate to severe PMS and PMDD was 11.2% and 3.9%, respectively. The 45.7% of working women was found to suffer from reduced work performance. 'Working as a director' (OR8.70,95%CI:1.22-120.0), 'difficulty concentrating' (OR3.17,95%CI:1.05-10.6), and 'fatigue or lack of energy'(OR5.94,95%CI:1.33-34.6) increased the risk of poor work performance. Conclusions: This study showed that premenstrual symptoms affect not only the daily activities but also the work performance of employee women.

Keywords:

PMS, PMDD, working women,

PDF

___

1.Freeman EW. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology 2003;28( 3):25–37.
2. Halbreich U. The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder—clinical procedures and research perspectives. Gynecol Endocrinol 2004;19:320–34.
3.Hylan TR, Sundell K, Judge R. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France. J Womens Health Gend Based Med 1999;8:1052.
4. Johnson SR, McChesney C, Bean JA. Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior. J Reprod Med 1988;33:340–6.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 2000. p. 771–4.
6. Yang M, Wallenstein G, Hagan M, Guo A, Chang J, Kornstein S. Burden of premenstrual dysphoric disorder on health-related quality of life. J Womens Health (Larchmt) 2008;17:113–21.
7. Panay N. Management of premenstrual syndrome. J Fam Plann Reprod Health Care 2009Jul;35(3):187-94.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Department of Health and Human Services,Washington, DC, U.S. 1994.
9. Diener D, Greenstein FL, Turnbough PD. Cyclical variation in digit-span and visual-search performance in women differing in the severity of their premenstrual symptoms. Percept. Mot. Skills 1992;74: 67–76.
10. Borenstein J, Chiou CF, Dean B, Wong J, Wade S. Estimating direct and indirect costs of premenstrual syndrome. J Occup Environ Med 2005;47:26–33.
11. Dean BB, Borenstein JE. A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome. J Occup Environ Med 2004;46:649–56.
12. Gonda X, Telek T, Juhász G, Lazary J, Vargha A, Bagdy G. Patterns of mood changes throughout the reproductive cycle in healthy women without premenstrual dysphoric disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008;32:1782–88.
13. Reed SC, Levin FR, Evans SM. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder). Hormones and Behavior 2008;54:85–193.
14. Takeda T, Tasaka K,Sakata M, Murata Y. Prevalence of premenstrual syndrome and premenstrual dystrophic disorder. Arch Womens Ment Health 2006;9:209.
15. Borenstein J, Chiou CF, Dean B, Wong J, Wade S. Estimating directand indirect costs of premenstrual syndrome. J Occup Environ Med 2005;47:26–33.
16. Dean BB, Borenstein JE. A prospective assessment investigating therelationship between work productivity and impairment with premenstrualsyndrome. J Occup Environ Med 2004;46:649–56.
17. Borenstein J E, Dean BB, Leifke E, Korner P, Yonkers K A. Differences in symptom scores and health outcomes in premenstrual syndrome. Journal of Women's Health 2007;16: 1139–44.
18. Chawla A, Swindle R, Long S, Kennedy S, Sternfeld B. Premenstrual dysphoric disorder is there an economic burden of illness. Medical Care 2002;40: 1101–12.
19. Nillni YI, Toufexis DJ, Rohan KJ. Anxiety sensitivity, the menstrual cycle, and panic disorder: A putative neuroendocrine and psychological interaction. Clin Psychol Rev. 2011Nov;31(7):1183-91.